Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
424studies shown
Showing 121-132 of 424
Drug study icon
RecruitingNCT03817502

Cariprazine for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Bulgaria, in Colombia, ...

Multiple locations, including Sofia
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 13 Years to 17 Years
Countries
United States, Bulgaria, Colombia, ...
Sponsor
Gedeon Richter Plc.
Condition
Schizophrenia
Device study icon
RecruitingNCT06888726

Efficacy of Hi-tACS for Schizophrenia Negative Symptoms

This summary needs review. Please check the official study record and contact the research team for details.

In Shanghai
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
Drug study icon
RecruitingNCT07227818

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Garden Grove
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Neurocrine Biosciences
Condition
Schizophrenia
Other study type icon
RecruitingNCT06236048

Energetics and Glutamate in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In London
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 65 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT06961916

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2)

This summary needs review. Please check the official study record and contact the research team for details.

In Houston
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 60 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Schizophrenia
Drug study icon
RecruitingNCT07288333

Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Kazanlak
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United Kingdom, Bulgaria, Romania
Sponsor
Neurocrine Biosciences
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.